<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref035">
 <label>[35]</label>
 <mixed-citation publication-type="journal">
  <string-name>
   <surname>Hanganu</surname>
   <given-names>A</given-names>
  </string-name>, 
  <string-name>
   <surname>Degroot</surname>
   <given-names>C</given-names>
  </string-name>, 
  <string-name>
   <surname>Monchi</surname>
   <given-names>O</given-names>
  </string-name>, 
  <string-name>
   <surname>Bedetti</surname>
   <given-names>C</given-names>
  </string-name>, 
  <string-name>
   <surname>Mejia-Constain</surname>
   <given-names>B</given-names>
  </string-name>, 
  <string-name>
   <surname>Lafontaine</surname>
   <given-names>AL</given-names>
  </string-name>, 
  <string-name>
   <surname>Chouinard</surname>
   <given-names>S</given-names>
  </string-name>, 
  <string-name>
   <surname>Bruneau</surname>
   <given-names>MA</given-names>
  </string-name> (
  <year>2014</year>) 
  <article-title>Influence of depressive symptoms on dopaminergic treatment of Parkinsonâ€™s disease</article-title>. 
  <source>Front Neurol</source>
  <volume>5</volume>, 
  <fpage>188</fpage>.
  <pub-id pub-id-type="pmid">25309508</pub-id>
 </mixed-citation>
</ref>
